¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pyrimidine antibiotics"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® antibiotics ÇÑ±Û Ç×»ýÁ¦
¼³¸í   
  ¹Ì»ý¹°ÀÌ ¸¸µé¾î³»´Â Ç×»ý ¹°Áú·Î µÈ ¾àÁ¦. ´Ù¸¥ ¹Ì»ý¹°À̳ª »ý¹° ¼¼Æ÷¸¦ ¼±ÅÃÀûÀ¸·Î ¾ïÁ¦Çϰųª Á×ÀδÙ. ¹Ì»ý¹°¿¡ ÀÇÇØ »ý»êµÇ¸ç ¹Ì»ý¹°ÀÇ ¹ßÀ° ¶Ç´Â ¾Ç¼ºÁ¾¾çÀÇ Áõ½ÄÀ» ÀúÁöÇϴ ¹°ÁúÀÌ´Ù. ¼÷ÁÖ¿¡ ¹«ÇØÇÑ Ç×»ý¹°ÁúÀº »ç¶÷-µ¿¹°-½Ä¹°ÀÇ ¼¼±Õ°¨¿°ÁõÀÇ Ä¡·á¿¡ È­Çпä¹ýÁ¦·Î »ç¿ëÇÑ´Ù. ±× ÀÛ¿ë¸ÞÄ¿´ÏÁòÀº ¹Ì»ý¹°ÀÇ ¼¼Æ÷º®À» ÇÕ¼ºÇϴ °ÍÀ» ÀúÇØÇϴ °Í, ÇÙ»ê(DNA, RNA) ÇÕ¼ºÀúÇØ, ´Ü¹éÁú ÇÕ¼ºÀúÇØ, º¸È¿¼ÒÇÕ¼ºÀúÇØ µîÀÌ ÀÖ´Ù. ÀÛ¿ë¸ÞÄ¿´ÏÁò°ú È­Çб¸Á¶¿¡ µû¶ó ¥â-¶ôްè(Æä´Ï½Ç¸°·ù), ¾Æ¹Ì³ë´ç·ù°è, Åׯ®¶ó»çÀÌŬ¸°°è, Å¬·Î¶÷Æä´ÏÄݰè, Æú¸®ÆéƼµå°è, ±âŸ(¸°ÄÚ¸¶À̽Å, ¹ÝÄÚ¸¶À̽еî)·Î ºÐ·ùµÈ´Ù. Ç×Á¾¾çÇ×»ý¹°Áú¿¡´Â ¾Æµå¸®¾Æ¸¶À̽Å, ¾ÇƼ³ë¸¶À̽ÅD, ¸¶ÀÌÅ丶À̽ÅC, ºí·¹¿À¸¶À̽еîÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibiotics
    Ç×»ýÁ¦(ù÷ßæð¥)
  • pyrimidine
    ÇǸ®¹Ìµò.
  • pyrimidine
    ÇǸ®¹Ìµò
  • pyrimidine-5-nucleotidase
    ÇǸ®¹Îµò-5-´©Å¬·¹¿ÀƼ´ÙÁ¦
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò.
  • pyrimidine
    ÇǸ®¹Ìµò
  • pyrimidine-5-nucleotidase
    ÇǸ®¹Îµò-5-´©Å¬·¹¿ÀƼ´ÙÁ¦
  • antibiotics
    Ç×»ýÁ¦(ù÷ßæð¥)
  • bacteriostatic antibiotics
    Á¤±Õ¼º Ç×»ý¹°Áú(¡­àõù÷ßæÚªòõ).
  • beta-lactam antibiotics
    º£Å¸-¶ôŽÇ×»ýÁ¦.
  • intestinal antibiotics
    Àå°ü¿ë Ç×»ý¹°Áú(íóηéÄ ù÷ßæÚªòõ).
  • intestinal antibiotics
    Àå°ü¿ë Ç×»ý¹°Áú(íóηéÄù÷ßæÚªòõ).
  • peptide antibiotics
    ÆÕƼµåÇ×»ýÁ¦
  • prophylactic antibiotics
    ¿¹¹æÀû Ç×»ýÁ¦
  • resistance to antibiotics
    Ç×»ýÁ¦ÀúÇ×¼º(ù÷ßæð¥î½ù÷àõ), Ç×»ýÁ¦³»¼º(ù÷ßæð¥ Ò±àõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine antibiotics
    ÇǸ®¹Ìµò Ç×»ýÁ¦(ù÷ßæð¥)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò
  • pyrimidine analogue
    ÇǸ®¹Ìµò À¯»çü(×¾ÞÄô÷)
  • pyrimidine dimer
    ÇǸ®¹Ìµò ÀÌÇÕü(ì£ùêô÷)
  • aminoglycoside antibiotics
    ¾Æ¹Ì³ë±Û¶óÀÌÄÚ»çÀ̵å Ç×»ýÁ¦(ù÷ßæð¥)
  • antitumor antibiotics
    Ç×Á¾¾ç Ç×»ýÁ¦(ù÷ðþåËù÷ßæð¥)
  • beta lactam antibiotics
    º£Å¸ ¶ôŽ Ç×»ýÁ¦(ù÷ßæð¥)
  • depsipeptide antibiotics
    µª½ÃÆéŸÀ̵å Ç×»ýÁ¦(ù÷ßæð¥)
  • ion-translocating antibiotics
    ÀÌ¿ÂÀüÀ§ Ç×»ýÁ¦(ï®êÈù÷ßæð¥)
  • purine antibiotics
    Ç»¸° Ç×»ýÁ¦(ù÷ßæð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • broadsoectrum antibiotics
    ±¤¹üÀ§Ç×»ýÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
MPP massive peritoneal proliferation; methyl phenylpyridinium; medical personnel pool; mercaptopyrazide ...
TEF Tracheo-Esophageal Fistula
  ? Tx
    1. Infant Warmer
 ...
NOABX no antibiotics
ORALABX oral antibiotics
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGs Aminoglycoside antibiotics
AB Antibiotics
trimethoprim 2,4-diamino)-5-(3,4,5-trimethoxy-benzyl)-pyrimidine
4-APP 4-amino-pyrazolo-(3,4 d) pyrimidine
CPD Cyclobutane pyrimidine dimer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pyrimidine antagonist
    ÇǸ®¹Ìµò ±æÇ×Á¦
  • aminoglycoside antibiotics
    ¾Æ¹Ì³ë±Û¸®ÄÚ»çÀ̵å Ç×»ýÁ¦
    ½ºÅ×·¾Å丶À̽Å, °¡³ª¸¶À̽Å, °ÕŸ¸¶À̽Å, ¾Æ¹ÌÄ«½Å, Åäºê¶ó¸¶À̽еîÀÌ ÀÖ´Ù. ±¤¹üÀ§ Ç×±Õ ½ºÆåÆ®·³À» Áö´Ï°í ±×¶÷ À½¼º °£±Õ¿¡ ´ëÇØ¼­µµ È¿°úÀûÀÌ´Ù. ƯÈ÷ Ç׻꼺 ±Õ¿¡ È¿°úÀûÀ̰í PAS³ª INAH¿Í º´¿ëÇØ¼­ Ä¡·á¿¡ »ç¿ëµÈ´Ù.
  • antibiotics
    Ç×»ýÁ¦
    ¾î¶² »ý¹° ȤÀº ¹Ì»ý¹°¿¡¼­ »ý¼ºµÇ´Â ¹°Áú·Î¼­ ´Ù¸¥ ¹Ì»ý¹°ÀÇ ¼ºÀå ¹× ¹ßÀ°À» ¾ïÁ¦ ȤÀº »ç¸ê½ÃŰ´Â ¹°Áú. ¼÷ÁÖ¿¡ ¹«ÇØÇÑ È¯°æ ¹°ÁúÀº »ç¶÷, µ¿¹°, ½Ä¹°ÀÇ ¼¼±Õ °¨¿°Áõ Ä¡·áÀÇ È­Çпä¹ýÁ¦·Î »ç¿ëµÈ´Ù.
  • bacteriostatic antibiotics
    Á¤±Õ¼º Ç×»ý ¹°Áú
    ¼¼±ÕÀÇ ¹ßÀ°, Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â È¿°ú°¡ ÀÖ´Â Ç×»ý ¹°Áú.
  • beta-lactam antibiotics
    º£Å¸-¶ôŽ Ç×»ýÁ¦
  • broad spectrum antibiotics
    ±¤¹üÀ§ Ç×»ýÁ¦, ±¤¿ª Ç×»ýÁ¦
  • chloramphenicol group antibiotics
    Ŭ·Î¶÷Æä´ÏÄݱº Ç×»ýÁ¦
  • intestinal antibiotics
    Àå°ü¿ë Ç×»ý ¹°Áú
  • PCN-resistant-lactam antibiotics

    PDGF (Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
pyrimidine <biochemistry> A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They are planar and aromatic in character and include several nucleic acid constituents (cytosine, thymine, and uracil) and form the basic structure of the barbiturates.
It is the parent compound of the pyrimidine bases of nucleic acid.
(21 Jun 2000)
pyrimidine-5'-nucleotide nucleosidase <enzyme> Also acts on some deoxyribonucleotides
Registry number: EC 3.2.2.10
Synonym: pyr-5'-nt-nucleosidase
(26 Jun 1999)
pyrimidine(6-4)pyrimidone photolyase <enzyme> Catalyses the light-dependent repair of pyrimidine(6-4)pyrimidone photoproducts; shows 20-22% sequence identity with class I cpd photolyase; genbank d83701 (drosophila), d83702 (human)
Registry number: EC 4.1.99.-
Synonym: (6-4)photolyase
(26 Jun 1999)
pyrimidine base <biochemistry> A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They are planar and aromatic in character and include several nucleic acid constituents (cytosine, thymine, and uracil) and form the basic structure of the barbiturates.
It is the parent compound of the pyrimidine bases of nucleic acid.
(21 Jun 2000)
pyrimidine deoxyribonucleoside kinase <enzyme> Consider also thymidine kinase (EC 2.7.1.21) or deoxycytidine kinase (EC 2.7.1.74)
Registry number: EC 2.7.-
Synonym: pyrimidine drn kinase
(26 Jun 1999)
pyrimidine dimer <biochemistry> A dimer product found in DNA chains damaged by ultraviolet irradiation. Most frequently thymidine dimers.
They consist of two adjacent pyrimidine nucleotides, usually thymine nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers stop DNA replication.
(21 Jun 2000)
pyrimidine-guanine sequence-specific ribonuclease <enzyme> From yolk granules of adult rana catesbeiana oocytes
Registry number: EC 3.1.27.-
Synonym: rc-rnase, rana catesbeiana rnase
(26 Jun 1999)
pyrimidine-nucleoside phosphorylase <enzyme> Consider uridine phosphorylase and thymidine phosphorylase
Registry number: EC 2.4.2.2
Synonym: pyrimidine nucleoside phosphorylase
(26 Jun 1999)
pyrimidine phosphoribosyltransferase <enzyme> Pyrimidine monophosphate and pyrophosphate gives pyrimidine and phosphoribosyl pyrophosphate; acts with uracil, orotic acid or fluorouracil
Registry number: EC 2.4.2.-
(26 Jun 1999)
pyrimidine transferase <enzyme> An enzyme catalyzing transfer of a pyridine or other bases into the position of the pyrimidine in thiamin; e.g., thiamin reacting with pyridine produces heteropyrithiamin and 4-methyl-5-(2'-hydroxyethyl)-thiazole.
Synonym: pyrimidine transferase, thiaminase I.
(05 Mar 2000)
antibiotics Drugs that fight infections.
(12 Dec 1998)
antibiotics, aminoglycoside Antibiotics whose structure contains amino sugars attached to an aminocyclitol ring (hexose nucleus) by glycosidic bonds. Aminoglycoside antibiotics are derived from various species of streptomyces and micromonospora or are produced synthetically. They act by inhibiting protein synthesis.
(12 Dec 1998)
antibiotics, anthracycline Antibiotics which have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to a sugar molecule. These antibiotics have potent antineoplastic activity. The two best known members of this group are daunorubicin and doxorubicin. Since these agents intercalate with DNA, many DNA functions are adversely affected. Futhermore they interact with cell membranes thereby altering their functions and also generate hydrogen peroxide and hydroxy radicals which are highly destructive to cells.
(12 Dec 1998)
antibiotics, antifungal Antibiotics inhibiting the growth of or killing fungi and used in the treatment of various fungal diseases.
(12 Dec 1998)
antibiotics, antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the development of neoplasms.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrimidine
    ÇǸ®¹Ìµò(»ýü Áß¿¡¼­´Â ÇÙ»êÀÇ ±¸¼ººÐÀ¸·Î Á¸ÀçÇÔ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á